Drug Type Small molecule drug |
Synonyms TEPIK, IY7640 |
Target |
Action inhibitors |
Mechanism hemagglutinin inhibitors(Influenza virus hemagglutinin glycoproteins inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Virus Diseases | Preclinical | South Korea | 30 Jan 2022 | |
| Influenza, Human | Preclinical | South Korea | 01 Sep 2019 | |
| Influenza, Human | Preclinical | South Korea | 01 Sep 2019 |





